Projects per year
- 200 - 250 out of 382 results
Search results
-
Potential therapeutic targeting of CaMK1D in Hodgkin lymphoma 2020
Kearns, P., Berditchevski, F. & Murray, P.
BIRMINGHAM WOMEN'S CHARITABLE FUNDS
1/04/20 → 31/03/21
Project: Research
-
Completion of a Clinical Trial Fellowship; gaining a wealth of experience of clinical trials at different stages from conception through to completion to develop skills enabling a future career to accelerate progress in curing cancer.
Fenwick, N., Wheatley, K., Kearns, P. & Bowden, S.
Cancer Research Uk, University Hospitals Bristol NHS Foundation Trust
1/03/17 → 30/04/21
Project: Research
-
CATALYST: A randomised early phase adaptive trial for new drugs for SARS-CoV-2+ patients
Gates, S., Parekh, D., Bowden, S., Kearns, P., Bion, J., Slade, D., Middleton, G., Patel, J., Thickett, D., Fisher, B., Newsome, P., Gao Smith, F., Rowe, A., Sharpe, R., Mussai, F. & Sapey, E.
1/06/20 → 31/05/21
Project: Research Councils
-
TIER - APhase I/II Study of Thiotepa, Ifosphamide, Etoposide & Rituximab for the treatment of relapsed & refractory primary central nervous system lymphoma
Siddique, S. & Jackson, A.
15/01/14 → 1/06/21
Project: Research
-
Brevity: A Phase II Study of Brentuximab vedotin (SGN-35) using a response adapted design in patients with Hodgkin Lymphoma unsuitable for chemotherapy due to age, fraility or co-morbidity
Fenwick, N. & Siddique, S.
MILLENNIUM PHARMACEUTICALS INC
5/02/14 → 30/06/21
Project: Research
-
Assessment of the Mechanism of Action of PCI-32765 in B-Cell Receptor Pathway Inhibition in CLL
Fenwick, N.
1/05/14 → 31/08/21
Project: Research
-
A Phase 1b Study of Eltromobopag and Azacitidine in Patients with High Risk Myelodysplastic Syndromes and Related Disorders (ELAstic)
Fenwick, N.
Glaxosmithkline, CELGENE INTERNATIONAL SARL
1/10/14 → 30/09/21
Project: Research
-
Stratified Medicene Matrix Trial
Middleton, G., Billingham, L. & Steven, N.
Cancer Research Uk, ASTRA ZENECA UK LIMITED, INIVATA LTD
1/08/14 → 31/10/21
Project: Research
-
European Paediatric Soft Tissue Sarcoma Study Group
CHILDREN'S CANCER AND LEUKAEMIA GROUP
1/01/15 → 31/12/21
Project: Research
-
LenaRic: A phase II study of adjuvant use of lenalidomide in patients undergoing reduced intensity condtioning allogenic transplantation for multiple myeloma
Craddock, C.
Uhb Nhs Trust, Cancer Research Uk
1/04/11 → 31/12/21
Project: Research
-
A Randomised, Double Blind Placebo-Controlled study to Investigate the Safety, Tolerability and clinical activity of GSK1070806 in the Treatment of Patients with Moderate-to-Severe Crohn's Disease
Barton, D., Ghosh, S., Iacucci, M., Bach, S. & Brock, K.
1/05/18 → 31/12/21
Project: Industry
-
-
Effects of Tamoxifen on the Mutant Allele Burden and Disease Course in Patients with Myeloproliferative Neoplasms
Craddock, C., Siddique, S. & Jackson, A.
1/12/15 → 31/12/21
Project: Research
-
OCTAVE: Observational patient Cohorts-T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2
Rea, D., Moss, P., Kirkham, A., Richter, A. & Kearns, P.
1/01/21 → 31/01/22
Project: Research
-
(Ext of RHBD06608 & RHBD12673) A Large Randomised Assessment of the Relative Cost-Effectiveness of Classes of Drugs for Parkinson's Disease
Clarke, C. E., Rowland, N., Wheatley, K. & Windridge, D.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/11/11 → 31/01/22
Project: Other Government Departments
-
Cancer Research UK Clinical Trial Fellowship in Paediatric Oncology
Kearns, P. & Fenwick, N.
Cancer Research Uk, Birmingham Childrens Hospital
1/01/20 → 31/01/22
Project: Research
-
A randomised trial comparing surgical and radiotherapy strategies enabling rational treatment selection for primary Merkel Cell Carcinoma (MCC), a rare virus and immune-related aggressive skin cancer (Rational MCC)
Steven, N., Bowden, S. & Gough, R.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/01/16 → 28/02/22
Project: Other Government Departments
-
Paediatric Oncology Clinical Trials Fellowship: Birmingham CRCTU
Kearns, P., Wheatley, K., Brookes, S., Lawson, A. & Mussai, F.
Cancer Research Uk, BIRMINGHAM WOMENS NHS TRUST
1/03/19 → 28/02/22
Project: Research
-
Midland & Wales Advanced Therapy Treatment Centre (ATTC)
Newsome, P., Ghosh, S., Craddock, C., Calvert, M. & Filer, A.
1/03/18 → 31/03/22
Project: Other Government Departments
-
Patient-reported outcomes assessment to support accelerated access to advanced cell and gene therapies:PROmics
Calvert, M., Newsome, P., Kyte, D., Harding, R. & Rowe, A.
1/12/18 → 31/03/22
Project: Other Government Departments
-
MW-ATTC - Runway
Calvert, M., Newsome, P., Craddock, C., Sharpe, R., Filer, A. & Curbishley, S.
1/04/21 → 31/03/22
Project: Other Government Departments
-
IMPACT: The UK's Stem Cell Transplant Clinical Trials Platform
Kearns, P. & Craddock, C.
ANTHONY NOLAN, NHS BLOOD & TRANSPLANT, LEUKA
1/01/17 → 1/08/22
Project: Research
-
ROMICAR: Phase I/II study to determine the maximum tolerated dose and overall response rate of the combination of romidepsin and carfilzomib in relapsed or refractory peripheral T-cell lymphoma
Fox, S. & Fenwick, N.
CELGENE INTERNATIONAL II SARL, BLOODWISE, ONYX PHARMACEUTICALS INC
1/08/15 → 31/08/22
Project: Research
-
NIHR Biomedical Research Centre (BRC) - Trials Theme
Kearns, P., Drayson, M. & Newsome, P.
NIHR CENTRAL COMMISSIONING FACILITY
1/04/17 → 30/11/22
Project: Other Government Departments
-
TAP-Minihub: Proposal for a Trials Acceleration Programme (TAP) Minihub 2019
Fox, S. & Craddock, C.
1/01/20 → 31/12/22
Project: Research
-
Assessment of the Mechanism of Action of CAL-101 in B-Cell Receptor Pathway Inhibition in CLL
Siddique, S. & Fenwick, N.
GILEAD SCIENCES INTERNATIONAL LTD, BLOODWISE
1/04/14 → 31/12/22
Project: Research
-
-
A Phase 1B Clinical Trial of BKM120 with Bortezomib in Defned Genetic Subgroups of Patients with Relapsed or Refractory Multiple Myeloma
Fenwick, N.
NOVARTIS PHARMACEUTICALS UK LTD, Janssen-Cilag Limited
9/11/15 → 1/01/23
Project: Research
-
Phase 1 COVID-19 Immunity - National Core Study (Phase 1 IMM-NCS) PHASE 1 - OCTAVE ADOLESCENT: linked to Project 1617675 and Original Award WT:1568864
Medical Research Council, NIHR
15/12/21 → 31/03/23
Project: Research Councils
-
The Big Baby Study
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/09/18 → 31/03/23
Project: Other Government Departments
-
Birmingham ECMC
Beggs, A., Moss, P., Kearns, P., Craddock, C., Nankivell, P., Willcox, B., Morton, D., Middleton, G., Khoja, L., Drayson, M., Tomlinson, I., Steven, N., Taylor, M., Watts, C. & Mehanna, H.
1/04/17 → 31/03/23
Project: Research
-
Phase 1 COVID-19 Immunity – National Core Study (Phase 1 IMM-NCS) PHASE 1 - OCTAVE DUO
Rea, D., Kirkham, A., Richter, A. & Kearns, P.
BLOODWISE, Medical Research Council
1/08/21 → 31/03/23
Project: Research Councils
-
Queen Elizabeth Hospital Birmingham Charity Grant
Rea, D.
University Hospital Birmingham NHS Foundation Trust
1/05/19 → 30/04/23
Project: Research
-
A Phase II pilot safety and tolerability study of ILB in patients with Motor Neurone Disease (MND)/ Amyotrophic Lateral Sclerosis(ALS)
Logan, A., Bach, S., Barton, D., Brock, K. & Smith, D.
1/06/18 → 20/08/23
Project: EU
-
Cancer Research UK Clinical Trials Unit, Birmingham - Paediatric Unit
Kearns, P., Bach, S., Bowden, S., Rea, D., Steven, N., Craddock, C., Billingham, L. & Wheatley, K.
1/10/18 → 30/09/23
Project: Research
-
Cancer Research UK Clinical Trials Unit, Birmingham - Adult Unit
Bach, S., Bowden, S., Craddock, C., Rea, D., Kearns, P., Wheatley, K., Billingham, L. & Steven, N.
1/10/18 → 30/09/23
Project: Research
-
Development of a synthetic flowable dressing that prevents corneal scarring
Rauz, S., Spyropoulos, F., Barnes, N., Billingham, L., Wallace, G., Grover, L. & Logan, A.
1/08/16 → 30/09/23
Project: Research Councils
-
OCTAVE DUO - Phase 2 funds: Linked to Phase 1 - Project 1722784
Kearns, P., Rea, D., Richter, A. & Kirkham, A.
13/08/21 → 30/09/23
Project: Research Councils
-
-
(to 28/02/14) CRUK/02/013: High Risk Neuroblastoma Study 1 of SIOP - Europe (Extension)
Cancer Research Uk, St. Anna Kinderkrebsforschung
1/04/10 → 30/11/23
Project: Research
-
MICA Potential of P2X7 receptor antagonism to attenuate the adverse consequences of neurotrauma (PROTECT)
Barnes, N., Bach, S., Belli, T., Di Pietro, V., Brock, K., Barton, D., Logan, A., Lax, S., Lax, S., Billingham, L., Bowden, S. & Bowden, S.
1/12/20 → 30/11/23
Project: Research Councils